Cellebrite DI (NASDAQ:CLBT – Get Free Report) and monday.com (NASDAQ:MNDY – Get Free Report) are both mid-cap technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations and institutional ownership.
Analyst Ratings
This is a summary of recent ratings and target prices for Cellebrite DI and monday.com, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cellebrite DI | 1 | 0 | 5 | 0 | 2.67 |
| monday.com | 1 | 9 | 14 | 1 | 2.60 |
Cellebrite DI currently has a consensus price target of $16.70, indicating a potential upside of 51.13%. monday.com has a consensus price target of $117.91, indicating a potential upside of 29.96%. Given Cellebrite DI’s stronger consensus rating and higher possible upside, equities analysts plainly believe Cellebrite DI is more favorable than monday.com.
Risk and Volatility
Institutional and Insider Ownership
45.9% of Cellebrite DI shares are held by institutional investors. Comparatively, 73.7% of monday.com shares are held by institutional investors. 5.7% of Cellebrite DI shares are held by company insiders. Comparatively, 22.3% of monday.com shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Cellebrite DI and monday.com’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cellebrite DI | 11.43% | 15.58% | 8.29% |
| monday.com | 8.87% | 9.09% | 4.73% |
Valuation & Earnings
This table compares Cellebrite DI and monday.com”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cellebrite DI | $514.29 million | 5.36 | $78.33 million | $0.22 | 50.23 |
| monday.com | $1.37 billion | 3.40 | $118.74 million | $2.35 | 38.61 |
monday.com has higher revenue and earnings than Cellebrite DI. monday.com is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.
Summary
monday.com beats Cellebrite DI on 8 of the 15 factors compared between the two stocks.
About Cellebrite DI
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.
About monday.com
monday.com Ltd., together with its subsidiaries, develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally. The company provides Work OS, a cloud-based visual work operating system that consists of modular building blocks used and assembled to create software applications and work management tools. Its products include monday work management that manages workflows, projects, and portfolios for team collaboration and productivity; monday sales CRM, whcih tracks and manages various sales cycle; monday dev that builds agile product and software development workflows; WorkCanvas, a digital whiteboard; and WorkForms, which allows users to create personalized forms or surveys and gain organizational insights. It serves organizations, educational or government institution, and distinct business unit of an organization. The company was formerly known as DaPulse Labs Ltd. and changed its name to monday.com Ltd. in December 2017. monday.com Ltd. was incorporated in 2012 and is headquartered in Tel Aviv, Israel.
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
